Bluejay Diagnostics (BJDX) EBT (2022 - 2023)

Historic EBT for Bluejay Diagnostics (BJDX) over the last 2 years, with Q2 2023 value amounting to -$2.9 million.

  • Bluejay Diagnostics' EBT fell 4622.81% to -$2.9 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$10.8 million, marking a year-over-year change of. This contributed to the annual value of -$7.8 million for FY2024, which is 2281.35% up from last year.
  • Per Bluejay Diagnostics' latest filing, its EBT stood at -$2.9 million for Q2 2023, which was down 4622.81% from -$2.7 million recorded in Q1 2023.
  • Bluejay Diagnostics' EBT's 5-year high stood at -$2.0 million during Q2 2022, with a 5-year trough of -$2.9 million in Q2 2023.